Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)

NCT: NCT06511934 · RECRUITING

NCT IDNCT06511934
StatusRECRUITING
Start Date2024-07-22
Completion2027-07-30
SponsorLeigh R. Hochberg, MD, PhD. (OTHER)
First posted
Last updated

Brief Summary

People with brainstem stroke, advanced amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), or other disorders can become unable to move or speak despite being awake and alert. In this project, the investigators seek to further translate knowledge about interpreting brain signals related to movement, and to further develop an intracortical brain-computer interface (iBCI) that could restore rapid and intuitive use of communication apps on tablet computers by people with paralysis.

Frequently Asked Questions

What is Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)?

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01) is a clinical trial registered under NCT06511934. Current status: RECRUITING.

What is the status of NCT06511934?

The current status of NCT06511934 (Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)) is: RECRUITING.

When did Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01) start?

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01) started on 2024-07-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.